The rejoinder submissions and evidence of the Canadian Government has been posted in Eli Lilly’s NAFTA Chapter 11 arbitration against the Canadian government relating to the utility of Eli Lilly’s Zyprexa and Strattera patents.
See my earlier posts on this proceeding:
- September 25, 2015 – Reply submissions
- February 9, 2015 – Counter memorial
- October 21, 2014 – Eli Lilly’s Memorandum
- July 14, 2014 – Canada’s Statement of Defence
- September 13, 2013 – Notice of Arbitration
- December 10, 2012 – Notice of Intent